Ovarian renin-angiotensin system-regulating aminopeptidases are involved in progesterone overproduction in rats with mammary tumours induced by N-methyl nitrosourea

Anticancer Research

Volumn 29, Issue 11, 2009, Pages 4633-4637

  Carrera, María Del Pilar ^a   Ramírez Expósito, María Jesús ^a   García, María Jesús ^b   Mayas, María Dolores ^c   Martínez Martos, José Manuel ^a  

^a UNIVERSITY OF JAÉN   (Spain)

^b Laboratorio Central de Sanidad Animal   (Spain)

^c HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Breast cancer; Estradiol; Ovary; Renin angiotensin system; Steroidogenesis

Indexed keywords

AMINOPEPTIDASE B; ANGIOTENSIN II; ANGIOTENSIN III; ASPARTYL AMINOPEPTIDASE; GLUTAMYL AMINOPEPTIDASE; METHYLNITROSOUREA; MICROSOMAL AMINOPEPTIDASE; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST TUMOR; CANCER THERAPY; CATABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; METABOLISM; NONHUMAN; OVARY; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROGESTERONE SYNTHESIS; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STEROIDOGENESIS;

AMINOPEPTIDASES; ANIMALS; ESTRADIOL; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLNITROSOUREA; OVARY; PROGESTERONE; RATS; RATS, WISTAR; RENIN-ANGIOTENSIN SYSTEM;

EID: 75149162421     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Bernstein L: Epidemiology of endocrine-related risk factors for breast cancer. J Mammary Gland Biol Neoplasia 7: 3-15, 2002.
2. Russo J and Russo IH: The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol 102: 89-96, 2006.
3. Russo IH and Russo J: Hormonal approach to breast cancer prevention. J Cell Biochem Suppl 34: 1-6, 2000.
4. Gullino PM, Pettigrew HM and Grantham FH: N-Nitrosomethylurea as mammary gland carcinogen in rats. J Natl Cancer Inst 54: 401-414, 1975.
5. McCormick DL, Adamowski CB, Fiks A and Moon RC: Lifetime dose-response relationships for mammary tumor induction by a single administration of N-methyl-N-nitrosourea. Cancer Res 41: 1690-1694, 1981.
6. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR and van Zwieten MJ: Comparative study of human and rat mammary tumorigenesis. Lab Invest 62: 244-278, 1990.
7. Thompson HJ and Adlakha H: Dose-responsive induction of mammary gland carcinomas by the intraperitoneal injection of 1-methyl-1-nitrosourea. Cancer Res 51: 3411-3415, 1991.
8. Welsch CW: Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res 45: 3415-3443, 1985.
9. Nielsen AH, Hagemann A and Poulsen K: The tissue reninangiotensin system in the female reproductive tissues. A review. Adv Exp Med Biol 377: 253-268, 1995.
10. Husain A, Bumpus FM, De Silva P and Speth RC: Localization of angiotensin II receptors in ovarian follicles and the identification of angiotensin II in rat ovaries. Proc Natl Acad Sci USA 84: 2489-2493, 1987.
11. Speth RC, Bumpus FM and Husain A: Identification of angiotensin II receptors in the rat ovary. Eur J Pharmacol 130:351-352, 1986.
12. Haulica I, BiId W and Serban DN: Angiotensin peptides and their pleiotropic actions. J Renin Angiotensin Aldosterone Syst 6: 121-131, 2005.
13. Peppered JR, Nemeth G, Yamada Y, Naftolin F and Merino M: Localized accumulation of angiotensin II and production of angiotensin-(1-7) in rat luteal cells and effects on steroidogenesis. Am J Physiol Endocrinol Metab 291: E221-233, 2006.
14. Schultze D, Brunswig B and Mukhopadhyay AK: Renin and prorenin-like activities in bovine ovarian follicles. Endocrinology 124: 1389-1398, 1989.
15. Speth RC and Husain A: Distribution of angiotensin-converting enzyme and angiotensin II-receptor binding sites in the rat ovary. Biol Reprod 38: 695-702, 1988.
16. Obermuller N, Schlamp D, Hoffmann S, Gentili M, Inagami T, Gretz N and Weigel M: Localization of the mRNA for the angiotensin II receptor subtype 2 (AT2) in follicular granulosa cells of the rat ovary by nonradioactive in situ hybridization. J Histochem Cytochem 46: 865-870, 1998.
17. Kuo TC, Endo K, Dharmarajan AM, Miyazaki T, Atlas SJ and Wallach EE: Direct effect of angiotensin II on in vitro perfused rabbit ovary. J Reprod Fertil 2: 469-474, 1991.
18. Yoshimura Y, Karube M, Koyama N, Shiokawa S, Nanno T and Nakamura Y: Angiotensin II directly induces follicle rupture and oocyte maturation in the rabbit. FEBS Lett 307: 305-308, 1992.
19. Yoshimura Y, Karube M, Aoki H, Oda T, Koyama N, Nagai A, Akimoto Y, Hirano H and Nakamura Y: Angiotensin II induces ovulation and oocyte maturation in rabbit ovaries via the AT2 receptor subtype. Endocrinology 137: 1204-1211, 1996.
20. Pepperell JR, Nemeth G, Yamada Y and Naftolin F: The type 1 angiotensin-II receptor mediates intracellular calcium mobilization in rat luteal cells. Endocrinology 133: 1678-1684, 1993.
21. Reaux A, Fournie-Zaluski MC and Llorens-Cortes C: Angiotensin III: a central regulator of vasopressin release and blood pressure. Trends Endocrinol Metab 12: 157-162, 2001.
22. Barrett AJ, Woessner JF and Rawlings ND: Handbook of Proteolytic Enzymes. Amsterdam, Elsevier/Academic Press, 2004.
23. Szczepanska-Sadowska E: Interaction of vasopressin and angiotensin II in central control of blood pressure and thirst. Regul Pept 66: 65-71, 1996.
24. Beynon RJ and Bond JS: Proteolytic Enzymes: A Practical Approach. Oxford, Oxford University Press, 2001.
25. Ward PE, Benter IF, Dick L and Wilk S: Metabolism of vasoactive peptides by plasma and purified renal aminopeptidase M. Biochem Pharmacol 40: 1725-1732, 1990.
26. de la Chica-Rodriguez S, Cortes-Denia P, Rarmirez-Exposito MJ, de Saavedra JM, Sanchez-Agesta R, Perez MC and Martinez-Martos JM: Doxazosin blockade of alpha 1-adrenergic receptors increases rat serum progesterone levels: a putative role of ovarian angiotensin III in steroidogenesis. Fertil Steril 88: 1071-1075, 2007.
27. Rivera ES, Andrade N, Martin G, Melito G, Cricco G, Mohamad N, Davio C, Caro R and Bergoc RM: Induction of mammary tumors in rat by intraperitoneal injection of NMU: histopathology and estral cycle influence. Cancer Lett 86: 223-228, 1994.
28. Carrera MP, Ramirez-Exposito MJ, Valenzuela MT, Garcia MJ, Mayas MD and Martinez-Martos JM: Glutamyl- but not aspartyl-aminopeptidase activity is modified in serum of N-methyl nitrosourea-induced rat mammary tumours. Anticancer Res 24: 801-805, 2004.
29. Carrera MP, Ramirez-Exposito MJ, Valenzuela MT, Duenas B, Garcia MJ, Mayas MD and Martinez-Martos JM: Reninangiotensin system-regulating aminopeptidase activities are modified in the pineal gland of rats with breast cancer induced by N-methyl-nitrosourea. Cancer Invest 24: 149-153, 2006.
30. Garcia MJ, Martinez-Martos JM, Mayas MD, Carrera MP and Ramirez-Exposito MJ: Hormonal status modifies reninangiotensin system-regulating aminopeptidases and vasopressin-degrading activity in the hypothalamus-pituitary-adrenal axis of male mice. Life Sci 73: 525-538, 2003.
31. Henderson BE and Feigelson HS: Hormonal carcinogenesis. Carcinogenesis 21: 427-433, 2000.
32. Preston-Martin S, Pike MC, Ross RK, Jones PA and Henderson BE: Increased cell division as a cause of human cancer. Cancer Res 50: 7415-7421, 1990.
33. Mustafa IA and Bland KI: Physiologic effects of steroid hormones and postmenopausal hormone replacement on the female breast and breast cancer risk. Ann Surg 228: 638-651, 1998.
34. Martin G, Melito G, Rivera E, Levin E, Davio C, Cricco G, Andrade N, Caro R and Bergoc R: Effect of tamoxifen on intraperitoneal N-nitroso-N-methylurea-induced tumors. Cancer Lett 100: 227-234, 1996.
35. McGuire WL, Osborne CK, Clark GM and Knight WA, 3rd.: Steroid hormone receptors and carcinoma of the breast. Am J Physiol 243: E99-102, 1982.
36. Topper YJ and Freeman CS: Multiple hormone interactions in the developmental biology of the mammary gland. Physiol Rev 60: 1049-1106, 1980.
37. Alexander IE, Clarke CL, Shine J and Sutherland RL: Progestin inhibition of progesterone receptor gene expression in human breast cancer cells. Mol Endocrinol 3: 1377-1386, 1989.
38. Nardulli AM and Katzenellenbogen BS: Progesterone receptor regulation in T47D human breast cancer cells: analysis by density labeling of progesterone receptor synthesis and degradation and their modulation by progestin. Endocrinology 122: 1532-1540, 1988.
39. Read LD, Snider CE, Miller JS, Greene GL and Katzenellenbogen BS: Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines. Mol Endocrinol 2: 263-271, 1988.
40. Clarke CL, Roman SD, Graham J, Koga M and Sutherland RL: Progesterone receptor regulation by retinoic acid in the human breast cancer cell line T-47D. J Biol Chem 265: 12694-12700, 1990.
41. Graham JD and Clarke CL: Physiological action of progesterone in target tissues. Endocr Rev 18: 502-519, 1997.
42. Johnson MC, Vega M, Vantman D, Troncoso JL and Devoto L: Regulatory role of angiotensin II on progesterone production by cultured human granulosa cells. Expression of angiotensin II type-2 receptor. Mol Hum Reprod 3: 663-668, 1997.
43. Ross RK, Paganini-Hill A, Wan PC and Pike MC: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst 92: 328-332, 2000.
44. Schairer C, Byrne C, Keyl PM, Brinton LA, Sturgeon SR and Hoover RN: Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States). Cancer Causes Control 5: 491-500,1994.